Synonyms: AUM-601 | AUM601 | CHC 2014 | CHC2014 | Chemical Compound 50 [US20160168156A1] [1] | HL 5101 | HL5101 | NOV 1601 | NOV-1601
Compound class:
Synthetic organic
Comment: We mapped the structure for the INN boditrectinib via PubChem to research code AUM601, which is a selective, orally bioavailable pan-tropomyosin related kinase (TRK; a.k.a., neurotrophin tyrosine receptor kinase, NTRK) inhibitor [1]. It inhbits wild-type NTRKs and variants with resistance mutations. AUM601 is an oncology clinical lead that's being developed by AUM Biosciences. Previous research codes include CHC2014 and NOV1601.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
(E)-3-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-1-piperazin-1-ylprop-2-en-1-one |
International Nonproprietary Names | |
INN number | INN |
12591 | boditrectinib |
Synonyms | |
AUM-601 | AUM601 | CHC 2014 | CHC2014 | Chemical Compound 50 [US20160168156A1] [1] | HL 5101 | HL5101 | NOV 1601 | NOV-1601 |
Database Links | |
CAS Registry No. | 1940165-80-9 (source: WHO INN record) |
GtoPdb PubChem SID | 479821159 |
PubChem CID | 121395201 |
Search Google for chemical match using the InChIKey | BQFYCHBYISNPFW-SQZHUTIHSA-N |
Search Google for chemicals with the same backbone | BQFYCHBYISNPFW |
Search PubMed clinical trials | boditrectinib |
Search PubMed titles | boditrectinib |
Search PubMed titles/abstracts | boditrectinib |
UniChem Compound Search for chemical match using the InChIKey | BQFYCHBYISNPFW-SQZHUTIHSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | BQFYCHBYISNPFW-SQZHUTIHSA-N |